Elevance Health's Q2 2026 Earnings: What to Expect

Indianapolis, Indiana-based Elevance Health, Inc. (ELV) operates as a health benefits company in the United States. The company has a market cap of $83.4 billion and operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individuals and employer groups, including risk-based and fee-based plans, BlueCard, Medicare, Medicaid, and others.

ELV is expected to release its Q2 2026 earnings soon. Ahead of the event, analysts expect the company's EPS to be $6.18 on a diluted basis, down 30.1% from $8.84 in the year-ago quarter. The company has exceeded Wall Street's EPS estimates in three of its last four quarters, while missing on one occasion.

Mark Cuban Says There Are Some 'Greedy Blood-Sucking Business People That Will Do Anything for a Dollar' But 'Eat the Rich' Only Helps Politicians

Stocks Rally Before the Open on Upbeat Micron Earnings, U.S. PCE Inflation Data in Focus

Stocks Settle Mixed on Apple Weakness and Chipmaker Strength

Our exclusive Barchart Brief newsletter is your FREE midday guide to what's moving stocks, sectors, and investor sentiment - delivered right when you need the i

Fuente original: Yahoo Finance (https://finance.yahoo.com/healthcare/articles/elevance-healths-q2-2026-earnings-095252192.html)